GLP-1 RAs in the Spotlight: New Frontiers in Obesity Management

How to participate in the activity: Please visit the Medicine CE homepage to participate in this activity.

Target Audience: Physicians, Physician Assistants, and Nurse Practitioners
Type of Activity: Knowledge-based
Release and Most Recent Review Date: September 2, 2025
Expiration Date: September 2, 2026
Number of Credit Hours: 1.0 hour CME (1.0 AMA PRA Category 1 Credit)
Fee: Free

Purpose: To equip clinicians with the knowledge and skills needed to incorporate GLP-1 receptor agonists into individualized obesity treatment plans, overcome implementation barriers such as access and patient misconceptions, and improve weight-related and metabolic health outcomes across diverse patient populations

Learning Objectives:

  • Describe the pharmacologic mechanisms of GLP-1 receptor agonists and explain how these agents contribute to weight loss and metabolic regulation in patients with obesity.
  • Evaluate current clinical guidelines and emerging evidence supporting the use of GLP-1 receptor agonists in the management of obesity, including in non-diabetic populations.
  • Identify practical strategies for initiating, titrating, and monitoring GLP-1 therapy in diverse patient populations, with attention to safety, side effect management, and long-term adherence.
  • Recognize common barriers to access and implementation of GLP-1 therapies (such as cost, insurance coverage, and misconceptions) and develop approaches to address these challenges in clinical practice.

Speaker(s):
Faria Munir, PharmD—Author
Clinical Assistant Professor
Clinical Pharmacist, Drug Information
University of Illinois Chicago Retzky College of Pharmacy

Bernice Man, MD—Reviewer
Assistant Professor of Clinical Medicine
University of Illinois at Chicago College of Medicine

Disclosure(s): Drs. Munir and Man, the planning committee members, and reviewers who contributed to this activity have no relevant financial conflicts of interest to disclose.

CME

ACCME

How to Earn Credit:
Participants must complete the activity as described below in the Continuing Medical Education Statement by reading the learning objectives and faculty disclosures; participating in the entire knowledge-based activity consisting of reviewing the monograph, completion of the post-assessment,  activity evaluation, and estimating the duration of time spent on the activity. A certificate of completion will be issued after all requirements as described are completed.

Hardware/Software and Internet Requirements can be found at https://medicinece.uic.edu/.

Provider Contact Information:
For general information please email the Office of Continuing Education and Meeting Services at: pharmce@uic.edu. Copyright © 2025– The Board of Trustees of the University of Illinois. All rights reserved. Reproduction in whole or in part without permission is prohibited. Privacy Policy